• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

Cognizant and Yseop Partner to Deliver GenAI Medical Writing for Life Sciences

by Fred Pennic 07/11/2024 Leave a Comment

Cognizant and Yseop Partner to Deliver GenAI Medical Writing for Life Sciences

What You Should Know:  - Cognizant and Yseop, a leading AI software company, have joined forces to accelerate and streamline scientific content creation in the biopharmaceutical industry.  - The strategic partnership leverages Yseop Copilot, a generative AI tool, to transform medical writing, enhance productivity, and expedite the delivery of life-saving treatments. Challenges of Traditional Medical Writing The current process for creating scientific content is a
Read More

Uncapping Capacity: Solving for Technology Overload in Clinical Trials

by Melissa Easy, VP & General Manager of Clinical Technologies, IQVIA 07/10/2024 Leave a Comment

Uncapping Capacity: Solving for Technology Overload in Clinical Trials

The clinical trial landscape has greatly benefited from technological innovations over the past few decades. Innovation has expanded remote monitoring capabilities, patient recruitment tactics and the decentralization of clinical trials. However, one of the greatest hurdles that clinical researchers are currently facing is a deluge of disparate solutions across the clinical trial workflow. For example, surveys reveal that 60% of clinical research sites are using up to, and over, 20 systems on a
Read More

Verantos Launches Alzheimer’s Disease Pragmatic Registry to Support RWE Generation

by Syed Hamza Sohail 07/10/2024 Leave a Comment

Verantos Launches Alzheimer’s Disease Pragmatic Registry to Support RWE Generation

What You Should Know: - Verantos, the global leader in high-validity real-world evidence at scale, has launched its Alzheimer’s Disease Pragmatic Registry. - This registry offers life sciences organizations rich and reliable data on patients with Alzheimer’s disease and related conditions. Verantos: Leading High-Validity Real-World Evidence Verantos is the global leader in high-validity real-world evidence at scale. By applying artificial intelligence to comprehensive patient
Read More

Tasso & InnoVero to Supply Anti-Doping Test to 2024 Paris Olympics, Expanded Partnership

by Syed Hamza Sohail 07/10/2024 Leave a Comment

asso & InnoVero to Supply Anti-Doping Test to 2024 Paris Olympics, Expanded Partnership

What You Should Know: - InnoVero, a global leader in providing innovative, athlete-centric collection technologies to anti-doping organizations worldwide and Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the extension of their partnership that was first initiated in 2021. - In addition to collaboratively developing new athlete-centric solutions, InnoVero will continue to serve as the exclusive worldwide distributor of Tasso
Read More

Courier Health Raises $16.5M for First Patient CRM for Biopharma

by Fred Pennic 07/09/2024 Leave a Comment

Courier Health Raises $16.5M for First Patient CRM for Biopharma

What You Should Know:  - Courier Health, a technology company transforming patient experiences in the life sciences industry raises $16.5M in Series A funding led by Norwest Venture Partners with participation from existing investor Work-Bench.  - The investment fuels Courier Health's mission to provide biopharma companies with the tools to manage and personalize the patient journey for life-altering therapies. Addressing the Rise of Specialty Medicines The landscape of
Read More

Pangea Biomed’s ENLIGHT-DP Predicts Cancer Treatment Response from Simple Scans

by Fred Pennic 07/03/2024 Leave a Comment

Pangea Biomed's ENLIGHT-DP Predicts Cancer Treatment Response from Simple Scans

What You Should Know:  - Pangea Biomed, a leader in precision oncology, announced a significant breakthrough in its ENLIGHT cancer response predictor. A new study published in Nature Cancer demonstrates the effectiveness of their ENLIGHT-DP platform, revealing its ability to predict cancer treatment response across various types and drugs using only routine pathology slides. - While these findings are promising, further validation and testing are planned for regulatory
Read More

Biopharma at a Crossroads: AI Offers Key to R&D Reinvention

by Fred Pennic 07/01/2024 Leave a Comment

Biopharma at a Crossroads: AI Offers Key to R&D Reinvention

What You Should Know:  - A new report by Accenture, "Reinventing R&D in the Age of AI," paints a clear picture: the biopharmaceutical industry stands at a critical juncture. Companies that embrace intelligent technologies like AI and machine learning are poised to become the future's leaders, while those clinging to outdated methods risk falling behind. - Accenture's report serves as a roadmap, offering valuable insights and practical steps for companies ready to embrace the
Read More

VenoStent Raises $20M for Dialysis Solution, Secures $3.6M NIH Grant for U.S. Dialysis Therapeutic Clinical Trial

by Fred Pennic 06/27/2024 Leave a Comment

VenoStent Raises $20M for Dialysis Solution, Secures $3.6M NIH Grant for U.S. Dialysis Therapeutic Clinical Trial

What You Should Know:  - VenoStent, Inc., a medical device company pioneering a new approach to improve dialysis patient outcomes, announced the successful completion of its Series A funding round. The round closed at $20M, with Norwest Venture Partners contributing an additional $4M to join Good Growth Capital and IAG Capital Partners as co-leads. - VenoStent also welcomes Dr. Zack Scott, Norwest General Partner, and Dr. Ehi Akhirome, Norwest Investor, to its board of
Read More

Clinical Trial Diversity: Pharma Takes Action to Address Disparities

by Fred Pennic 06/26/2024 Leave a Comment

Clinical Trial Diversity: Pharma Takes Action to Address Disparities

What You Should Know:  - Trinity Life Sciences, a leader in global life sciences commercialization solutions, has released a new white paper titled "Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA's Latest Guidance."  - The paper sheds light on the critical issue of racial and ethnic diversity in clinical trials, exploring current industry initiatives, their effectiveness, and the future landscape shaped by the FDA's evolving
Read More

How Vertical Commercial Optimization Platforms Help Pharma Companies Do Omnichannel Marketing Right

by Shahar Cohen, CTO at Verix 06/26/2024 Leave a Comment

How Vertical Commercial Optimization Platforms Help Pharma Companies Do Omnichannel Marketing Right

In a world full of options, companies need to compete on every prospect and existing customer. As the number of potential channels to reach customers increases, companies need to build strategies for interacting with the right customers, through the right channels, at the right time and with the right messages. Omnichannel marketing has emerged as an effective and efficient means for optimizing this customer engagement. However, while omnichannel is far from being simple in any industry, it
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 19
  • Go to page 20
  • Go to page 21
  • Go to page 22
  • Go to page 23
  • Interim pages omitted …
  • Go to page 87
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |